In 2010, Jeff T. Bowles began a series of ebook bestsellers to publish health issues that deal with the problem of healing and aging from an evolutionary perspective. By joining the simple logic of evolution with a large number of diverse facts as well as the results of his 25-year-old private research, Jeff was able to demonstrate a wide range of new, simple and very effective ways to relieve many chronic diseases, such as multiple sclerosis, asthma or age-related diseases such as Alzheimer's and ALS. Jeff was the first person who could show in a rat experiment (1997-2001) that rats whose water intake is restricted, live significantly longer (even longer than restricting food). 1998 in the journal Medical Hypotheses his article "The Evolution of Aging - A New Approach to an Old Problem of Biology" was published. Later he published there two other articles. His hypothesis that the suppression of a certain hormone can stop the progression of Alzheimer's disease, resulted in the founding of the company Voyager Pharmaceuticals, which showed in a 50-Million dollar project, that the suppression of the hormone LH in women actually prevented the progression of Alzheimer's disease. In his proto-book about ALS he predicted in January of 2013 that progesterone would be the first effective treatment for ALS ever. Six months later some Korean researchers showed that progesterone dramtically extended the lives of male mice in a mouse model of ALS-the equivalent of 17 human years whereas most ALS patients only survive 2 to 4 years.